Information on IRF4-DN

Basic details

Name: Combined immunodeficiency with skin-hair depigmentation | Acronym: IRF4-DN
Alt. names: Early-onset PAD with T cell anomalies and skin-hair depigmentation | Hypogammaglobulinemia, T cell abnormalities and skin-hair depigmentation

Gene: IRF4 | MOI: Autosomal dominant | Mechanism of action: Negative Dominance

No. of cases in DB: 4 | First reported in: 2023

Last updated on: 2024-10-25 16:39:55 by Xiao P. Peng

OMIM:

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

Thouenon et al. (2023) described a heterozygous neomorphic IAD domain variant (c.1075 T>C, p.(F359L)) in 3 patients from a 2-generation family who presented with hypogammaglobulinemia and early onset recurrent bacterial, viral and fungal infections, predominantly sinorespiratory, GI and mucocutaneous, as well as skin and hair depigmentation (PMID: 36917008). One patient developed TNF inhibitor-responsive inflammatory bowel disease and liver disease with evidence of prominent CD8+ T cell infiltration on pathology. Despite normal overall B cell counts and normal proportions of switched memory B cells in adulthood, all patients had lower proportions of immature T and B cell populations in the blood – namely, reduced naïve vs memory T cells and reduced plasmablast/plasma cell counts. Two patients also showed absolute T cell lymphopenia. Defective IRF4 mutant protein showed altered binding at ISRE, which leads to defective plasma cell differentiation.

Management

Description of management option has not been reviewed yet.

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.

4 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code
105347arrow icon M 215709 53 0 PMID:36917008 [P1(II.-)]
105348arrow icon M 215710 0 0 PMID:29408330 [P1(II.-)]
105349arrow icon F 215711 4 PMID:29408330 [P2]
105352arrow icon M 215714 2 PMID:36917008 [P3]

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 (unusual) Respiratory tract infectionarrow icon 3 (75.0%) 0 (0.0%) 1 (25.0%)
2 Recurrent upper respiratory tract infectionarrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
3 Lung diseasearrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
4 Enteropathyarrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
5 Diarrheaarrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
6 Varicella zoster virus infectionarrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
7 Hypogammaglobulinemiaarrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
8 (unusual) Viral infectionarrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
9 Abnormality of hair pigmentationarrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
10 Pneumoniaarrow icon 2 (50.0%) 0 (0.0%) 2 (50.0%)
11 Cytomegalovirus colitisarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
12 Hepatopathyarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
13 Hepatosplenomegalyarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
14 Abnormal lymphoproliferationarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
15 (Unusual) bacterial infectionarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
16 Immunodeficiencyarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
17 Herpes Simplex Virus Infectionarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
18 Conjunctivitisarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
19 Frequent Giardia lamblia infestationarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
20 Spotty hypopigmentationarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
21 Depigmentation/hyperpigmentation of skinarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
22 Oral mucositisarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
23 Onychomycosisarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
24 Inflammation of the large intestinearrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
25 Neisseria meningitidis infectionarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
26 Panhypogammaglobulinemiaarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.